Physician profile
Fritz Roc
NPI 1790784411
$3,729.85
in general payments reported to CMS, 2019-2025
25 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,106 · 2020: $573 · 2021: $392 · 2022: $580 · 2023: $216 · 2024: $331 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $531.50 | 2019-2024 | Xarelto |
| Pfizer INC. | $505.85 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $456.48 | 2019-2025 | |
| Amgen INC. | $426.31 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.56 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $287.35 | 2019-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $246.70 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $203.75 | 2019-2025 | Farxiga, Brilinta |
| Boston Scientific Corporation | $111.88 | 2019-2022 | |
| Abbott Laboratories | $88.63 | 2019-2025 | Aveir, Jot Dx |
| Biotronik INC. | $69.15 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.54 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $54.45 | 2022-2025 | |
| Novo Nordisk INC | $47.34 | 2022-2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $46.32 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $39.36 | 2025 | Zepbound, Mounjaro |
| Amarin Pharma, INC. | $37.94 | 2019-2021 | |
| Philips North America LLC | $37.65 | 2019-2023 | |
| Abiomed | $32.26 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $30.14 | 2019-2022 | |
| Edwards Lifesciences Corporation | $25.03 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $24.42 | 2024 | Cobalt Dr Mri Surescan |
| Scpharmaceuticals INC. | $21.06 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $20.82 | 2019 | |
| Medtronic Vascular, INC. | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fritz Roc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.